Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers
-
Published:2024-05
Issue:
Volume:1238
Page:124123
-
ISSN:1570-0232
-
Container-title:Journal of Chromatography B
-
language:en
-
Short-container-title:Journal of Chromatography B
Author:
Luethi DinoORCID,
Rudin Deborah,
Straumann Isabelle,
Thomann Jan,
Avedisian Isidora,
Liechti Matthias E.,
Duthaler Urs
Reference20 articles.
1. MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial;Mitchell;Nat. Med,2023
2. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study;Mitchell;Nat. Med,2021
3. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems;Luethi;J. Psychopharmacol,2019
4. Pharmacological characterization of designer cathinones in vitro;Simmler;Br. J. Pharmacol,2013
5. Impact of cytochrome P450 2D6 function on the chiral blood plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its phase I and II metabolites in humans;Steuer;Plos One,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献